bio bombs

at the end of the life-science supply chain when endpoints are unmet or studies flush there are more sellers than buyers of the promise

mc 6.65

mc 19

mc 1.5

 

on the run

mc 222 sf 7

mc 3.39 sf 12

ocft mc 1

mc 941 sf 34

mc 35 sf 24

mc 102 sf 13

mc 76 sf 9

 

flinch

The price journey from disclosure of SEC subpoena November 2020 at 27 to SEC settlement December 2021 at 10. 

Shareholders are passive institutions: Blackrock, Vanguard, Norges plus a series of funds obliged to hold on.  

Insiders at 50%

So 400 million shares outstanding, 200 million floating, 23% of the float is short (45 million), Institutions at about 25% long. 10 million shares traded daily.

The hardest part about playing chicken is to know when to flinch

tantalizing covers

mc 3.8 sf 23 sec settlement

mc 881 sf 34

mc 30 sf 24

specialty retail

                                                   prices down, shorts up, insider buying

mc 1.99 sf 12 insider+

mc 1.58 sf 20 insider+

inside out

mc 57 pe 76 14x rev insiders bailing

mc 275 pe 56 18x rev next leg down

 

imagination

the numbers

index earnings per share doubled. the earnings multiple contracted by 40%. thinking that a doubling of earnings during a global economic contraction strains the imagination. either prices are too low or earnings were the result of creative spreadsheet warriors.

the technicals

interesting wave counts at ten-day intervals. prices tethered to declining moving averages with .65 retracements of expanding down legs.